<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Papaioannou D</submitter><funding>European Hematology Association</funding><funding>NCI NIH HHS</funding><pagination>1391-1400</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5541873</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>102(8)</volume><pubmed_abstract>Long non-coding ribonucleic acids (RNAs) are a novel class of RNA molecules, which are increasingly recognized as important molecular players in solid and hematologic malignancies. Herein we investigated whether long non-coding RNA expression is associated with clinical and molecular features, as well as outcome of younger adults (aged &lt;60 years) with &lt;i>de novo&lt;/i> cytogenetically normal acute myeloid leukemia. Whole transcriptome profiling was performed in a training (n=263) and a validation set (n=114). Using the training set, we identified 24 long non-coding RNAs associated with event-free survival. Linear combination of the weighted expression values of these transcripts yielded a prognostic score. In the validation set, patients with high scores had shorter disease-free (&lt;i>P&lt;/i>&lt;0.0</pubmed_abstract><journal>Haematologica</journal><pubmed_title>Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia.</pubmed_title><pmcid>PMC5541873</pmcid><funding_grant_id>U10 CA077658</funding_grant_id><funding_grant_id>U10 CA180882</funding_grant_id><funding_grant_id>P30 CA016058</funding_grant_id><funding_grant_id>R50 CA211524</funding_grant_id><funding_grant_id>R35 CA197734</funding_grant_id><funding_grant_id>U10 CA180861</funding_grant_id><funding_grant_id>U10 CA180850</funding_grant_id><funding_grant_id>U24 CA196171</funding_grant_id><funding_grant_id>U10 CA180821</funding_grant_id><funding_grant_id>P50 CA140158</funding_grant_id><funding_grant_id>TRTH73</funding_grant_id><pubmed_authors>Orwick SJ</pubmed_authors><pubmed_authors>Kolitz JE</pubmed_authors><pubmed_authors>Bundschuh R</pubmed_authors><pubmed_authors>Uy GL</pubmed_authors><pubmed_authors>Yan P</pubmed_authors><pubmed_authors>Papaioannou D</pubmed_authors><pubmed_authors>Wang ES</pubmed_authors><pubmed_authors>Stone RM</pubmed_authors><pubmed_authors>Volinia S</pubmed_authors><pubmed_authors>Mrozek K</pubmed_authors><pubmed_authors>Lucas DM</pubmed_authors><pubmed_authors>Garzon R</pubmed_authors><pubmed_authors>Nicolet D</pubmed_authors><pubmed_authors>Blum W</pubmed_authors><pubmed_authors>Bloomfield CD</pubmed_authors><pubmed_authors>Carroll AJ</pubmed_authors><pubmed_authors>Kohlschmidt J</pubmed_authors><pubmed_authors>Powell BL</pubmed_authors><pubmed_authors>Byrd JC</pubmed_authors><pubmed_authors>Eisfeld AK</pubmed_authors><pubmed_authors>Caligiuri MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia.</name><description>Long non-coding ribonucleic acids (RNAs) are a novel class of RNA molecules, which are increasingly recognized as important molecular players in solid and hematologic malignancies. Herein we investigated whether long non-coding RNA expression is associated with clinical and molecular features, as well as outcome of younger adults (aged &lt;60 years) with &lt;i>de novo&lt;/i> cytogenetically normal acute myeloid leukemia. Whole transcriptome profiling was performed in a training (n=263) and a validation set (n=114). Using the training set, we identified 24 long non-coding RNAs associated with event-free survival. Linear combination of the weighted expression values of these transcripts yielded a prognostic score. In the validation set, patients with high scores had shorter disease-free (&lt;i>P&lt;/i>&lt;0.0</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Aug</publication><modification>2026-05-05T20:53:25.18Z</modification><creation>2026-04-07T21:58:37.777Z</creation></dates><accession>S-EPMC5541873</accession><cross_references><pubmed>28473620</pubmed><doi>10.3324/haematol.2017.166215</doi></cross_references></HashMap>